Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence, drug repurposing and peer review
Jeremy M. Levin, Tudor I. Oprea, Sagie Davidovich, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 10, pp. 1127-1131
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

DrugCentral 2021 supports drug discovery and repositioning
Sorin Avram, Cristian Bologa, Jayme Holmes, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1160-D1169
Open Access | Times Cited: 175
A critical overview of computational approaches employed for COVID-19 drug discovery
Eugene Muratov, Rommie E. Amaro, Carolina Horta Andrade, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9121-9151
Open Access | Times Cited: 174
TCRD and Pharos 2021: mining the human proteome for disease biology
Timothy Sheils, Stephen L. Mathias, Keith J. Kelleher, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1334-D1346
Open Access | Times Cited: 145
The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic
Francesco Piccialli, Vincenzo Schiano Di Cola, Fabio Giampaolo, et al.
Information Systems Frontiers (2021) Vol. 23, Iss. 6, pp. 1467-1497
Open Access | Times Cited: 109
Artificial Intelligence for Drug Discovery: Are We There Yet?
Catrin Hasselgren, Tudor I. Oprea
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 527-550
Open Access | Times Cited: 73
Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded
Laura Cresti, Giovanni Cappello, Alessandro Pini
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4870-4870
Open Access | Times Cited: 28
Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach
Chandra Bhushan Mishra, Preeti Pandey, Ravi Datta Sharma, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1346-1360
Open Access | Times Cited: 90
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Uttpal Anand, Shweta Jakhmola, Omkar Indari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 78
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
Sorin Avram, Thomas B. Wilson, Ramona Curpăn, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1276-D1287
Open Access | Times Cited: 47
Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications
Hao He, Hongrui Duo, Youjin Hao, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106671-106671
Closed Access | Times Cited: 21
Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains
Tzu-Tang Lin, Li-Yen Yang, Chung‐Yen Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6788-6788
Open Access | Times Cited: 21
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19
Giovanni Bocci, Steven B. Bradfute, Chunyan Ye, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 6, pp. 1278-1292
Open Access | Times Cited: 50
Overview of current state of research on the application of artificial intelligence techniques for COVID-19
Vijay Kumar, Dilbag Singh, Manjit Kaur, et al.
PeerJ Computer Science (2021) Vol. 7, pp. e564-e564
Open Access | Times Cited: 44
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs
Sharna-kay Daley, Geoffrey A. Cordell
Molecules (2021) Vol. 26, Iss. 13, pp. 3800-3800
Open Access | Times Cited: 41
Artificial intelligence-assisted tools for redefining the communication landscape of the scholarly world
Habeeb Ibrahim Abdul Razack, Sam T. Mathew, Fathinul Fikri Ahmad Saad, et al.
Science Editing (2021) Vol. 8, Iss. 2, pp. 134-144
Open Access | Times Cited: 41
The Future of ChatGPT in Medicinal Chemistry: Harnessing AI for Accelerated Drug Discovery
Tathagata Pradhan, Ojasvi Gupta, Gita Chawla
ChemistrySelect (2024) Vol. 9, Iss. 13
Closed Access | Times Cited: 5
Drug Repurposing by Siderophore Conjugation: Synthesis and Biological Evaluation of Siderophore‐Methotrexate Conjugates as Antibiotics
Sheng Zhao, Zhi‐Peng Wang, Zihua Lin, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 36
Closed Access | Times Cited: 22
Trends in orphan medicinal products approvals in the European Union between 2010–2022
L. Bouwman, Bruno Sepodes, Hubert G. M. Leufkens, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Open science approaches to COVID-19
Edwin G. Tse, Dana M. Klug, Matthew H. Todd
F1000Research (2020) Vol. 9, pp. 1043-1043
Open Access | Times Cited: 35
AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
Marcin Delijewski, Jacek Haneczok
Medicine in Drug Discovery (2020) Vol. 9, pp. 100077-100077
Open Access | Times Cited: 35
Longevity medicine: upskilling the physicians of tomorrow
Evelyne Bischof, Morten Scheibye‐Knudsen, Richard Siow, et al.
The Lancet Healthy Longevity (2021) Vol. 2, Iss. 4, pp. e187-e188
Open Access | Times Cited: 30
Using proteomic and transcriptomic data to assess activation of intracellular molecular pathways
Anton Buzdin, Victor Tkachev, Marianna Zolotovskaia, et al.
Advances in protein chemistry and structural biology (2021), pp. 1-53
Closed Access | Times Cited: 29
Artificial intelligence as an enabler of quick and effective production repurposing: an exploratory review and future research propositions
Farheen Naz, Anil Kumar, Rohit Agrawal, et al.
Production Planning & Control (2023) Vol. 35, Iss. 16, pp. 2154-2177
Open Access | Times Cited: 11
Managing Pandemics with Health Informatics: Successes and Challenges
Mujeeb Basit, Christoph U. Lehmann, Richard J Medford
Yearbook of Medical Informatics (2021) Vol. 30, Iss. 01, pp. 017-025
Open Access | Times Cited: 24
Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations
Jacek Haneczok, Marcin Delijewski
Journal of Biomedical Informatics (2021) Vol. 119, pp. 103821-103821
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top